These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The L-arginine-NO pathway and cyclic GMP in the vessel wall. Stoclet JC Z Kardiol; 1991; 80 Suppl 7():87-90. PubMed ID: 1665267 [TBL] [Abstract][Full Text] [Related]
14. Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats. Ozturk EI; Uma S J Cardiovasc Pharmacol; 2010 Nov; 56(5):498-505. PubMed ID: 20729759 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of pulmonary vascular control in normal and injured lungs. McIntyre RC; Harken AH; Fullerton DA Surgery; 1994 Mar; 115(3):273-5. PubMed ID: 8128350 [No Abstract] [Full Text] [Related]
17. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Morris CR; Morris SM; Hagar W; Van Warmerdam J; Claster S; Kepka-Lenhart D; Machado L; Kuypers FA; Vichinsky EP Am J Respir Crit Care Med; 2003 Jul; 168(1):63-9. PubMed ID: 12626350 [TBL] [Abstract][Full Text] [Related]
18. The clinical pharmacology of L-arginine. Böger RH; Bode-Böger SM Annu Rev Pharmacol Toxicol; 2001; 41():79-99. PubMed ID: 11264451 [TBL] [Abstract][Full Text] [Related]
19. [Biological role of metabolic pathways from L-arginine to nitric oxide]. Zembowicz A Folia Med Cracov; 1992; 33(1-4):103-16. PubMed ID: 1342993 [TBL] [Abstract][Full Text] [Related]
20. L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis? Siasos G; Tousoulis D; Antoniades C; Stefanadi E; Stefanadis C Int J Cardiol; 2007 Apr; 116(3):300-8. PubMed ID: 16860889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]